The urgent task of the global fight against the epidemic is to solve the vaccine deficit and close the “vaccine gap”. In the early days of the outbreak, China proposed that the new crown vaccine should be a global public good. So far, China has provided more than 1.85 billion doses of vaccines to more than 120 countries and international organizations around the world, and will strive to provide 2 billion doses in 2021. China’s vaccines are using their strength to make more and more countries vote “confidence”.

Continue to provide anti-epidemic support to countries

On December 8, the first batch of new crown vaccines and matching syringes under the emergency humanitarian supplies provided by the Chinese government to Afghanistan arrived at Kabul International Airport. Abdul Bari Omar, acting minister of public health of the Afghan interim government, said at the handover ceremony held at the airport that the epidemic, especially the latest variant of Omicron, has brought challenges to Afghanistan’s medical and health system, and the vaccines assisted by China will effectively enhance Afghanistan’s ability to fight the epidemic, for which Afghanistan is deeply grateful.

On November 25, the Chinese government provided Laos with a new batch of new crown vaccines and anti-epidemic materials. Lao Minister of Health Ben Phong thanked China for its assistance. He said that the epidemic is still raging, and China’s timely assistance truly reflects the friendship of the two countries to help each other, overcome difficulties together, and help each other in the same boat. It is believed that China’s strong support can help Laos increase the vaccination rate and build an immune barrier.

The handover ceremony of the first batch of new crown vaccines assisted by the Chinese government to the Jamaican government was held in Kingston, Jamaica, on November 24. When Jamaican Prime Minister Holness attended the ceremony, he sincerely thanked China for its valuable support and assistance in the fight against the epidemic. He said that the successful arrival of vaccines donated by China is the result of long-term, strong and sustained cooperation between the two countries, and Jamaica will learn from China’s experience, continue to vigorously carry out vaccination work, and continue to deepen the strategic partnership between the two countries.

The Philippine government-procured Chinese Sinovac vaccine arrived in Manila, the capital of the Philippines, in mid-November. Calito Galvez, the Philippine government’s general coordinator for the response to the new crown pneumonia epidemic, said: “China is a true friend, and Sinovac is a reliable supplier of vaccines. ”

China’s new batch of new crown vaccines to Syria was handed over on November 14. Syrian Minister of Health Hassan Gabbash said that China’s new batch of aid vaccines is of great significance under the current epidemic situation, which can help the Syrian health department promote and improve the national vaccination campaign, and this assistance is a witness to the continuous development of friendly relations between the two countries.

China’s donation of 1 million doses of Sinopharm vaccine and 1.16 million syringes to Peru arrived on November 13. Health workers in Lima, Peru’s capital, set up makeshift vaccination sites on main streets and commercial centers. Peru has received about 15 million doses of the Sinopharm vaccine.

On November 12, a batch of anti-epidemic materials such as China’s Kexing new crown vaccine, oxygen concentrator and oximeter was transferred to Thailand. Thai Prime Minister Prayut Chan-o-cha thanked China for its continuous anti-epidemic support and expressed Thailand’s willingness to further deepen R&D and production cooperation with China in vaccines and anti-epidemic drugs.

Chinese vaccines are safe and effective

The vaccine research and development special class of the scientific research group of the joint prevention and control mechanism of the State Council recently introduced that 26 new crown vaccines in China have entered the clinical trial stage, and 5 technical routes of inactivated vaccine, recombinant protein vaccine, adenovirus vector vaccine, nucleic acid vaccine and attenuated influenza virus vector vaccine have been fully covered. Among them, 14 vaccines have been approved for phase III clinical trials overseas, and the progress is generally smooth. Data show that Chinese vaccines have good safety and low side effects in more than 1 billion doses in countries with high epidemic prevalence abroad and more than 2 billion doses in China.

Sri Lanka’s Sri Jayawadna Pura University released a study on the effectiveness of China’s Sinopharm vaccine in July. The results showed that 95% of the population could produce antibodies after receiving two doses of Sinopharm vaccine, and 81.25% of the population could induce the production of neutralizing antibodies. Studies have also shown that Chinese vaccines have a clear effect on the Delta strain.

A survey of health sector staff by the Peruvian Ministry of Health showed that after two doses of Sinopharm vaccine, hospitalization rates were reduced by 87.8% and infection rates by 72.0%, indicating that Sinopharm vaccines effectively reduced the risk of illness among staff.

On November 18, Argentina’s National Vaccine Safety Commission released the “Child and Adolescent Vaccine Safety Report”, pointing out that among the actual vaccinations, Sinopharm vaccine applied the most doses, while the adverse event notification rate was the lowest. Rodrigue Chiloga, an Argentine biochemist and researcher, said in a social media post that the data confirmed that it is very safe for children to receive the new crown vaccine.

The results of Sinovac’s phase III clinical trials in Turkey and Indonesia showed that the protective data of vaccines against symptomatic infection were 83.5% and 65.3%, respectively.

On December 6, Chile began vaccinating children aged 3 to 5 with Sinovac vaccine, with the first vaccination for children of this age group with immunosuppression problems and underlying medical conditions. Chilean President Piñera said at the vaccination launch ceremony in the capital Santiago on the same day that the Sinovac vaccine is safe and effective and can provide protection for nearly 700,000 children aged 3 to 5 in Chile.

The Chilean Institute of Public Health announced emergency use authorization for Sinovac vaccines in people aged 3 to 5 years on November 25. Previously, the Chilean Institute of Public Health approved the Sinovac vaccine for emergency use in people aged 6 to 17 on September 6. The agency studied the vaccination of Sinovac vaccine in people aged 3 to 17 in China and the preliminary data of the phase III clinical trial of Sinovac vaccine at the Millennium Institute of Immunology and Immunotherapy of the Catholic University of Chile, and made the decision to expand the use of Sinovac vaccine to people over 3 years old.

According to the Venezuelan “Cosmos” website reported on November 5, Manuel Figuera, president of the Venezuelan Society of Infectious Diseases, said a few days ago that the vaccines of Sinopharm and Sinovac have been confirmed to be safe and effective. “These vaccines have been in use around the world for a long time, and several studies to date have confirmed their effectiveness and safety.”

Ecuador’s Ministry of Health recently announced that children aged 6 to 11 in the country will be vaccinated with the Chinese Sinovac vaccine from October 15. Ecuador’s ambassador to China, Carlos Larea, said Ecuador has full confidence in the quality of China’s vaccines, and China is the “backbone” that supports the country’s vaccination program.

Make a significant contribution to achieving equitable access to vaccines

At present, China has become the world’s largest provider of new crown vaccines, and most of the vaccines obtained by developing countries so far come from China. The Economist Intelligence Unit released a report that as of the end of October, more than 7 billion doses of vaccines have been administered worldwide, driven by Chinese vaccines, Chile and Cambodia vaccination rates have reached 79% and 77%, higher than developed countries such as the United States and Europe.

On November 17, at the ceremony to welcome the seventh batch of new crown vaccines from China to Cambodia, Cambodian Prime Minister Hun Sen said that China’s successive assistance and commercial procurement of vaccines have helped Cambodia complete the first phase of the national vaccination plan ahead of schedule, that is, vaccinating people over 6 years old across the country. At present, Cambodia is gradually reopening up in various fields, which has effectively promoted economic recovery. The successful implementation of Cambodia’s national vaccination program is inseparable from the new crown vaccines provided by China, which have become the key to maintaining public health security and saving people’s lives in Cambodia. “China is a true ‘hardcore friend’ of Cambodia and has always provided timely and unconditional support and assistance in Cambodia’s difficult times.”

The Prime Minister of Trinidad and Tobago announced via social media on November 13 that Prime Minister Raleigh had received a booster shot of the Sinopharm vaccine in the capital Port of Spain.

Serbian President Vučić received the third dose of Sinopharm vaccine in the capital Belgrade on November 7. He said he felt good after the vaccination and encouraged people to actively get vaccinated. Previously, Serbia had received several batches of Chinese-made COVID vaccines. Construction of a Serbian vaccine plant that will be used to produce Chinese coronavirus vaccines has also begun.

The Vaccine Implementation Plan, co-led by the World Health Organization, the Coalition for Epidemic Preparedness Innovations and Gavi, the Vaccine Alliance, aims to ensure equitable access to vaccines for all participating countries and economies. More than 500 million doses have been distributed to 144 countries and territories around the world. As of November 12, China has supplied more than 70 million doses of vaccines to the New Crown Vaccine Implementation Plan, and has carried out vaccine co-production with 19 developing countries, allowing Chinese vaccines to reach more countries faster and at lower cost.

Richard Hatchet, CEO of the Coalition for Epidemic Preparedness Innovation, said that China plays an important role in promoting international cooperation against the epidemic, focusing on sharing samples, sharing data and sharing response measures. By rapidly developing multiple vaccines and sharing them globally, “China has made great contributions to global efforts to achieve equitable access to vaccines, and we are very grateful for China’s contribution.”

Source: People’s Daily

“True friends”! China has provided more than 1.85 billion doses of vaccines globally